Literature DB >> 34782446

CD29 Enriches for Cytotoxic Human CD4+ T Cells.

Benoît P Nicolet1, Aurelie Guislain1, Monika C Wolkers2.   

Abstract

CD4+ T cells are key contributors in the induction of adaptive immune responses against pathogens. Even though CD4+ T cells are primarily classified as noncytotoxic helper T cells, it has become appreciated that a subset of CD4+ T cells is cytotoxic. However, tools to identify these cytotoxic CD4+ T cells are lacking. We recently showed that CD29 (integrin β1, ITGB1) expression on human CD8+ T cells enriches for the most potent cytotoxic T cells. In this study, we questioned whether CD29 expression also associates with cytotoxic CD4+ T cells. We show that human peripheral blood-derived CD29hiCD4+ T cells display a cytotoxic gene expression profile, which closely resembles that of CD29hi cytotoxic CD8+ T cells. This CD29hi cytotoxic phenotype was observed ex vivo and was maintained in in vitro cultures. CD29 expression enriched for CD4+ T cells, which effectively produced the proinflammatory cytokines IFN-γ, IL-2, and TNF-α, and cytotoxic molecules. Lastly, CD29-expressing CD4+ T cells transduced with a MART1-specific TCR showed target cell killing in vitro. In conclusion, we demonstrate in this study that CD29 can be employed to enrich for cytotoxic human CD4+ T cells.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34782446     DOI: 10.4049/jimmunol.2100138

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  3 in total

1.  RNA-Binding Protein Expression Alters Upon Differentiation of Human B Cells and T Cells.

Authors:  Nordin D Zandhuis; Benoit P Nicolet; Monika C Wolkers
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

2.  Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments.

Authors:  S M Castenmiller; R de Groot; A Guislain; K Monkhorst; K J Hartemink; A A F A Veenhof; E F Smit; J B A G Haanen; M C Wolkers
Journal:  Immunooncol Technol       Date:  2022-06-22

Review 3.  When Helpers Go Above and Beyond: Development and Characterization of Cytotoxic CD4+ T Cells.

Authors:  Cindy Hoeks; Gayel Duran; Niels Hellings; Bieke Broux
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.